Served as consulting expert to counsel for a pharmaceutical manufacturer alleged to have engaged in improper marketing practices, including off-label marketing and speaker programs, in violation of the False Claims Act. Supported counsel in analyzing causation and potential exposure based on trends in IQVIA prescribing data, third-party physician surveys, and Medicare and Medicaid prior authorization policies.
Partner with a firm that delivers rigorous economic research and practical advice.
By using this site, you agree to our updated Cookie Policy, Privacy Policy, and our Terms & Conditions.
When you visit our website, we use cookies on your browser to collect information. The information collected might relate to you, your preferences, or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. For more information about how we use cookies, please see our Cookie Policy and Privacy Policy.
